Fr. 300.00

Active Pharmaceutical Ingredients - Development, Manufacturing, and Regulation, Second Edition

English · Hardback

Shipping usually within 3 to 5 weeks

Description

Read more

Informationen zum Autor Stanley Nusim Klappentext To successfully bring an Active Pharmaceutical Ingredient (API) to market, many steps must be followed to ensure compliance with governmental regulations. Active Pharmaceutical Ingredients is an unparalleled guide to the development, manufacturing, and regulation of the preparation and use of APIs globally. Topics include:Safety, efficacy, and environmental/regulatory requirements Analysis of the recent movement of API manufacturing from the U.S. and Europe to countries such as India and China The FDA's intensified foreign inspection program Multi-use and flexible design facilities The shift from maintenance scheduling to built-in reliability This second edition focuses on the quality control regulations for APIs that have been added or amended since the first edition. These updates help ensure that pharmaceutical professionals and drug manufacturers meet the established and required guidelines set forth by the United States and international regulatory agencies. Zusammenfassung Active Pharmaceutical Ingredients Inhaltsverzeichnis 1. Introduction. 2. Process Development, Scaleup, and Design. 3. Technology Transfer and First Manufacture. 4. Plant Design and Construction. 5. Regulatory Requirements: US. 6. Regulatory Requirements: Outside US. 7. Process Validation. 8. Quality Assurance and Control. 9. Environmental Control. 10. Safety. 11. Plant Operations. 12. Bulk Sterile Manufacturing. 13. Materials Management. 14. Plant Maintenance.

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.